Latest

Groundbreaking Cancer Study: Nivolumab Delivers Remarkable Results for Endometrial Cancer Patients

Revolutionary Cancer Study: Nivolumab Yields Remarkable Results for Endometrial Cancer Patients

17 Березня, 2025
Nivolumab, an immunotherapy drug, shows an 80% complete response rate in phase 2 trials for resectable dMMR/MSI-H endometrial cancer. The trial results, announced at the 2025 SGO Annual Meeting, suggest reduced need for surgery among patients with total tumour remission. One patient
The Quantum Leap: How Big Tech’s Pursuit Could Revolutionize Our World

The Quantum Leap: How Big Tech’s Pursuit Could Revolutionise Our World

17 Березня, 2025
Quantum computing, powered by qubits, offers transformative capabilities through superposition and entanglement, enabling unprecedented data processing speeds. This technology poses challenges and opportunities for cryptography, necessitating quantum-safe encryption to secure digital communications and systems. In healthcare, quantum computing can revolutionise drug discovery
1 10 11 12 13 14 205